Perip7lakin is a target for autoimmunity in asthma - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Respiratory Research Année : 2016

Perip7lakin is a target for autoimmunity in asthma

Résumé

AbstractThe role of autoimmunity targeting epithelial antigens in asthma has been suggested, in particular in non-atopic and severe asthma. Periplakin, a desmosomal component, is involved in epithelial cohesion and intracellular signaling. We detected anti-periplakin IgG antibodies in 47/260 (18 %) patients with asthma, with no association with severity or atopy. In addition, anti-periplakin IgE antibodies were detected in 12 of 138 tested patients (8.7 %) and were more frequently observed in patients with than without nasal polyposis. This study identifies a new autoimmune epithelial target in asthma. Whether periplakin autoimmunity (both IgG and IgE auto-antibodies) is involved in asthma pathogenesis remains to be studied during the disease course of these patients.
Fichier principal
Vignette du fichier
12931_2016_Article_441.pdf (489.42 Ko) Télécharger le fichier
Origine : Publication financée par une institution
Loading...

Dates et versions

inserm-01377406 , version 1 (07-10-2016)

Identifiants

Citer

Camille Taillé, Sabine Grootenboer-Mignot, Candice Estellat, Carine Roy, Sophie Ly Ka So, et al.. Perip7lakin is a target for autoimmunity in asthma. Respiratory Research, 2016, 17 (1), pp.126. ⟨10.1186/s12931-016-0441-5⟩. ⟨inserm-01377406⟩
207 Consultations
76 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More